DPP4 and cancer: Focusing on its influence on metastasis, the outcomes fit with current evidence that cancer stem cell (CSC) subsets expressing CD26 are implicated in metastases of many cancers [38,47,48], including hematological [49], and the expression level of CD26 in these cells is associated with the prognosis of the disease [49].